Thrombophilic abnormalities of natural anticoagulants in patients with ulcerative colitis

Hepato-Gastroenterology

Volumn 54, Issue 77, 2007, Pages 1417-1421

  Zezos, Petros ^a   Papaioannou, Georgia ^b   Nikolaidis, Nikolaos ^a   Vasiliadis, Themistoclis ^a   Giouleme, Olga ^a   Evgenidis, Nikolaos ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

Author keywords

Activated protein C resistance; Antithrombin; Factor V Leiden; Protein C; Protein S; Thrombosis; Ulcerative colitis

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; CORTICOSTEROID DERIVATIVE; FIBRINOGEN; MERCAPTOPURINE; MESALAZINE; PROTEIN C; PROTEIN S;

ACTIVATED PROTEIN C RESISTANCE; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENDOSCOPY; FEMALE; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; MIDDLE AGED; THROMBOPHILIA;

EID: 34547625194     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Bargen JA, Barker NW: Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch Intern Med 1936; 58:17-31.
2. Edwards FC, Truelove SC: The course and prognosis of ulcerative colitis. Part III. Complications. Gut 1964; 5:1-22.
3. Talbot RW, Heppell J, Dozois RR, Beart RW Jr: Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986; 61:140-145.
4. Koenings KP, McPhedran P, Spiro HM: Thrombosis in inflammatory bowel disease. J Clin Gastroenterol 1987; 9:627-631.
5. Lee LC, Spittell JA Jr, Sauer WG, Owen CA Jr, Thompson JH Jr: Hypercoagulability associated with chronic ulcerative colitis: Changes in blood coagulation factors. Gastroenterology 1968; 54:76-85.
6. Lam A, Borda IT, Inwood MJ, Thomson S: Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology 1975; 68:245-251.
7. de Jong E, Porte RJ, Knot EA, Verheijen JH, Dees J: Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces. Gut 1989; 30:188-194.
8. Conlan MG, Haire WD, Burnett DA: Prothrombotic abnormalities in inflammatory bowel disease. Dig Dis Sci 1989; 34:1089-1093.
9. Vecchi M, Cattaneo M, de Franchis R, Mannucci PM: Risk of thromboembolic complications in patients with inflammatory bowel disease. Study of hemostasis measurements. Int J Clin Lab Res 1991; 21(2):165-170.
10. Hudson M, Hutton RA, Wakefield AJ, Sawyerr AM, Pounder RE: Evidence for activation of coagulation in Crohn's disease. Blood Coagul Fibrinolysis 1992; 3:773-778.
11. Collins CE, Cahill MR, Newland AC, Rampton DS: Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994; 106:840-845.
12. Souto JC, Martinez E, Roca M, Mateo J, Pujol J, Gonzalez D, Fontcuberta J: Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 1995; 40:1883-1889.
13. Bevilacqua MP, Gimbrone MA Jr: Inducible endothelial functions in inflammation and coagulation. Semin Thromb Hemost 1987; 13:425-433.
14. Jorens PG, Hermans CR, Haber I, Kockx MM, Vermylen J, Parizel GA: Acquired protein C and S deficiency, inflammatory bowel disease, and cerebral arterial thrombosis. Blut 1990; 61:307-310.
15. Aadland E, Odegaard OR, Roseth A, Try K: Free protein S deficiency in patients with chronic inflammatory bowel disease. Scand J Gastroenterol 1992; 27:957-960.
16. Aadland E, Odegaard OR, Roseth A, Try K: Free protein S deficiency in patients with Crohn's disease. Scand J Gastroenterol 1994; 29:333-335.
17. Koutroubakis IE, Sfiridaki A, Mouzas IA, Maladaki A, Kapsoritakis A, Roussomoustakaki M, Kouroumalis EA, Manousos ON: Resistance to activated protein C and low levels of free protein S in Greek patients with inflammatory bowel disease. Am J Gastroenterol 2000; 95:190-194.
18. Henegan MA, Cleary B, Murray M, O'Gorman TA, McCarthy CF: Activated protein C resistance, thrombophilia, and inflammatory bowel disease. Dig Dis Sci 1998; 39:1356-1361.
19. Liebman HA, Kashani N, Sutherland D, McGehee W, Kam AL: The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Gastroenterology 1998; 115:830-834.
20. Truelove SC, Witts LJ: Cortisone in ulcerative colitis: Br Med J 1955; 2:1041-1048.
21. Baron JH, Connell AM, Lennard-Jones JE: Variation between describing mucosal appearance in proctocolitis. Br Med J 1964; 1:89-92.
22. Jackson LM, O'Gorman PJ, O'Connell J, Cronin CC, Cotter KP, Shanahan F: Thrombosis in inflammatory bowel disease: Clinical setting, procoagulant profile and factor V Leiden. Quart J Med 1997; 90:183-188.
23. Sloan WP Jr, Bargen JA, Gage RB: Life histories of patients with chronic ulcerative colitis: A review of 2,000 cases. Gastroenterology 1968; 54(Suppl):819-822.
24. Graef V, Baggenstoss AH, Sauer WG, et al: Venous thrombosis in non-specific ulcerative colitis. A necropsy study. Arch Intern Med 1965; 117:377-382.
25. Bernstein CN, Blanchard JF, Houston DS, Wajda A: The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: A population-based cohort study. Thromb Haemost 2001; 85:430-434.
26. Johns DR: Cerebrovascular complications of inflammatory bowel disease. Am J Gastroenterol 1991; 86:367-370.
27. Maccini DM, Berg JC, Bell GA: Budd-Chiari syndrome and Crohn's disease. Dig Dis Sci 1989; 34:1933-1936.
28. Schneiderman JH, Sharpe JA, Sutton DM: Cerebral and retinal vascular complications of inflammatory bowel disease. Ann Neurol 1979; 5:331-337.
29. Keyser BJ, Hass AN: Retinal vascular disease in ulcerative colitis. Am J Opthalmol 1994; 118:395-396.
30. Juhlin L, Kranse U, Shelley WB: Endotoxin-induced microdots in ulcerative colitis and Crohn's disease. Scand J Gastroenterol 1980; 15:311-314.
31. Dhillon AP, Anthony A, Sim R, Wakefield AJ, Sankey EA, Hudson M, Alison MC, Pounder RE: Mucosal capillary thrombi in rectal biopsies. Histopathology 1992; 21:127-133.
32. Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Rowles PM, Lewis AA, Pounder RE: Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989; 2:1057-1062.
33. Thompson NP, Wakefield AJ, Pounder RE: Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 1995; 108:1011-1015.
34. Gaffney PR, Doyle CT, Gaffney A, Hogan J, Heys DP, Annis P: Paradoxical response to heparin in 10 patients with ulcerative colitis. Am J Gastronterol 1995; 90:220-223.
35. Torkvist L, Thorlacius H, Sjoqvist U, Bohman L, Lapidus A, Flood L, Agren B, Raud J, Lofberg R: Low molecular weight heparin as adjuvant therapy in active ulcerative colitis. Aliment Pharmacol Ther 1999; 13:1323-1328.
36. Rosendaal FR: Venous thrombosis: A multicausal disease. Lancet 1999; 353:1167-1173.
37. D'Angelo A, Vigano-D'Angelo S, Esmon CT, Comp PC: Acquired deficiencies of protein S. Protein S activity during oral anticoagulation, in liver disease, and in disseminated intravascular coagulation. J Clin Invest 1988; 81:1445-1454.
38. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Driven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-67.
39. De Stefano V, Finazzi G, Mannucci PM: Inherited thrombophilia: Pathogenesis, clinical syndromes, and management. Blood 1996; 87:3531-3544.
40. De Stefano V, Chiusolo P, Paciaroni K, Leone G: Epidemiology of factor V Leiden: Clinical implications. Semin Thromb Hemost 1998; 24:367-379.
41. Rees DC, Cox M, Clegg JB: World distribution of factor V Leiden. Lancet 1995; 346:1133-1134.
42. Grip O, Svensson PJ, Lindgren S: Inflammatory bowel disease promotes venous thromboses earlier in life. Scand J Gastroenterol 2000; 35:619-623.
43. Haslam N, Standen GR, Probert CS: An investigation of the association of the factor V Leiden mutation and inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999; 11:1289-1291.
44. Helio T, Wartiovaara U, Halme L, Turunen UM, Mikkola H, Palotie A: Arg506Gln factor V mutation and Val34Leu factor XIII polymorphism in Finnish patients with inflammatory bowel disease. Scand J Gastroenterol 1999; 34:170-174.
45. Guedon C, Le Cam-Duchez V, Lalaude O, Menard JF, Lerebours E, Borg JY: Prothrombotic inherited abnormalities other than factor V Leiden mutation do not play role in venous thrombosis in inflammatory bowel disease. Am J Gastroenterol 2001; 96:1448-1454.
46. Novacek G, Miehsler W, Kapiotis S, Katzenschlager R, Speiser W, Vogelsang H: Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease. Am J Gastronterol 1999; 94:685-690.
47. Zauber NP, Sabbath-Solitare M, Rajoria G, Mogan G: Factor V Leiden mutation is not increased in patients with inflammatory bowel disease. J Clin Gastronterol 1998; 27:215-216.
48. Lambropoulos AF, Foka Z, Makris M, Daly M, Kotsis A, Makris PE: Factor V Leiden in Greek thrombophilic patients: relationship with activated protein C resistance test and levels of thrombin-antithrombin complex and prothrombin fragment 1+2. Blood Coagul Fibrinolysis 1997; 8:485-489.
49. Papa A, Danese S, Grillo A, Gasparrini G, Gasparrini A: Review article: Inherited thrombophilia in inflammatory bowel disease. Am J Gastroenterol 2003; 98:1247-1251.